Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
PGIM India Healthcare Fund Regular Plan - IDCW Payout
PGIM India Mutual Fund₹12.18
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +21.80% | — | — |
| 3 year | +12.32% | — | — |
| 5 year | +12.32% | — | — |
All Sectoral Pharma and Healthcare funds · PGIM India Mutual Fund
Returns
From NAVs through 18 Aug 2026
Calendar years
Rolling 1-year · 9 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
32 holdings · portfolio as on 30 May 2026
- 11.34%Sun Pharmaceuticals Industries LtdHealthcare
- 10.01%Divi's Laboratories LtdHealthcare
- 6.53%J.B. Chemicals & Pharmaceuticals LtdHealthcare
- 6.44%Aster DM Healthcare Ltd Ordinary SharesHealthcare
- 5.97%Rubicon Research LtdHealthcare
- 5.24%Mankind Pharma LtdHealthcare
- 4.97%Max Healthcare Institute Ltd Ordinary SharesHealthcare
- 4.68%Ajanta Pharma LtdHealthcare
- 4.15%Krishna Institute of Medical Sciences LtdHealthcare
- 3.27%Dr. Lal Pathlabs LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
4 fund managers
- APAnandha Padmanabhan Anjeneyan5.3 years in the industryRuns 16 schemes
- PPPuneet Pal20.1 years in the industryRuns 36 schemes
- UMUtsav Mehta2.3 years in the industryRuns 8 schemes
- VSVivek Sharma1.9 years in the industryRuns 14 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-InsuredregularCompare
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund IDCW PayoutregularCompare
Bandhan Healthcare FundregularCompare
Bandhan BSE Healthcare Index Fund - Regular Plan - GrowthregularCompare
ICICI Prudential Healthcare ETFregularCompare
Axis Healthcare ETF Regular GrowthregularCompare
Motilal Oswal S&P BSE Healthcare ETFregularCompare
Nippon India Nifty Pharma ETF - Growth PlanregularCompare
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- regularGrowthPGIM India Healthcare Fund Regular Plan - GrowthNAV ₹10.09
- directIDCWPGIM India Healthcare Fund Direct Plan - IDCW ReinvestmentNAV ₹10.17
- directGrowthPGIM India Healthcare Fund Direct Plan - GrowthNAV ₹10.24
- regularIDCWPGIM India Healthcare Fund Regular Plan - IDCW ReinvestmentNAV ₹10
FAQ
What is PGIM India Healthcare Fund Regular Plan - IDCW Payout NAV today?
- The latest NAV of PGIM India Healthcare Fund Regular Plan - IDCW Payout is ₹12.18 as on 18 Aug 2026.
How has PGIM India Healthcare Fund Regular Plan - IDCW Payout performed vs its category?
- 1-year return +21.80%. Past performance does not guarantee future returns.
What are the returns of PGIM India Healthcare Fund Regular Plan - IDCW Payout?
- Trailing returns from published NAVs: 1 year +21.80%, 3 year +12.32% a year, 5 year +12.32% a year, since our first NAV +12.32% a year. Past performance does not guarantee future returns.
How would a SIP in PGIM India Healthcare Fund Regular Plan - IDCW Payout have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +12.32%. It is not a forecast.
What is the expense ratio and fund size of PGIM India Healthcare Fund Regular Plan - IDCW Payout?
- For PGIM India Healthcare Fund Regular Plan - IDCW Payout, the expense ratio is 2.47% and fund size (AUM) is ₹95.49 Cr.
What is the ISIN of PGIM India Healthcare Fund Regular Plan - IDCW Payout?
- The ISIN for PGIM India Healthcare Fund Regular Plan - IDCW Payout is INF663L01Z86.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.
